Xizang Haisco Pharmaceutical Group Co Ltd

002653 • SHE

¥68.88-¥0.27 (0.39%)

Estimate

P/E

99.8

EPS

0.69

Beta

-0.213

Growth

Revenue, YoY

75.33%

Net income, YoY

1,089.85%

FCF, YoY

468.12%

Forecast

P/E (FWD)

94.8

EPS (FWD)

0.727

Dividends

Dividend yield

0.78%

Annual payout

¥0.53

Next ex. div date

November 15, 26

Payout

23.34%

Div.growth, 5y

24.05%

Div.rating

About the company

Ticker

002653

ISIN

CNE100001BC7

Country

China

Sector (GICS)

Healthcare

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Frequently asked questions

What sector does Xizang Haisco Pharmaceutical Group Co Ltd (002653) operate in?

Xizang Haisco Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Xizang Haisco Pharmaceutical Group Co Ltd (002653) current stock price?

As of the latest data, Xizang Haisco Pharmaceutical Group Co Ltd stock price is CN¥68.88, with a previous close of CN¥69.15. Xizang Haisco Pharmaceutical Group Co Ltd lost -CN¥0.27 in the last trading session, representing a -0.39% loss.

What is Xizang Haisco Pharmaceutical Group Co Ltd (002653) current market capitalization?

Xizang Haisco Pharmaceutical Group Co Ltd market cap is approximately 77.14 billion.

What is Xizang Haisco Pharmaceutical Group Co Ltd (002653) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.69, and the forward EPS is CN¥0.73.

What is Xizang Haisco Pharmaceutical Group Co Ltd (002653) Price-to-Earnings (P/E) ratio?

Xizang Haisco Pharmaceutical Group Co Ltd current P/E ratio is 99.83, with a forward P/E of 94.78.

Does Xizang Haisco Pharmaceutical Group Co Ltd (002653) pay dividends?

Yes. Xizang Haisco Pharmaceutical Group Co Ltd pays semiannual dividends with an annualized yield of 0.78% and an estimated annual payout of CN¥0.53 per share.

When is the next ex-dividend date for Xizang Haisco Pharmaceutical Group Co Ltd (002653)?

The next ex-dividend date is scheduled for November 15, 2026.

What is Xizang Haisco Pharmaceutical Group Co Ltd (002653) beta (volatility) score?

Xizang Haisco Pharmaceutical Group Co Ltd has a beta of -0.213, indicating lower volatility than the overall market.